{"filing":{"accession_number":"0001104659-26-076352","cik":"0001868279","ticker":"AVBP","company_name":"ArriVent BioPharma, Inc.","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"tm2618466d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/tm2618466d1_8k.htm"},"events":[{"id":12716,"run_id":11284,"accession_number":"0001104659-26-076352","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of ArriVent BioPharma's June 18, 2026 annual meeting of stockholders, including the election of three Class II directors (James Healy, John Hohneker, and Stuart Lutzker) and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing provides detailed vote tallies for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.","company_name":"ArriVent BioPharma, Inc.","ticker":"AVBP","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9647,"accession_number":"0001104659-26-076352","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of ArriVent BioPharma's June 18, 2026 annual meeting of stockholders, including the election of three Class II directors (James Healy, John Hohneker, and Stuart Lutzker) and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing provides detailed vote tallies for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:46:53.071769+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9647,"accession_number":"0001104659-26-076352","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of ArriVent BioPharma's June 18, 2026 annual meeting of stockholders, including the election of three Class II directors (James Healy, John Hohneker, and Stuart Lutzker) and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing provides detailed vote tallies for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:46:53.071769+00:00","company_name":"ArriVent BioPharma, Inc.","ticker":"AVBP","filing_date":"2026-06-22"}]}